Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
23-Sep-16 Philips, Macquarie University's MQ Health, and Emory Healthcare of the US have announced Australia's first remote intensive care unit (eICU) monitoring program, aimed to help high risk patients in need of 'round-the-clock' observation. "We aim to transform the delivery of care to address growing clinician shortages while improving patient outcomes," said Kevin Barrow, Managing Director of Philips Australia. [image: HIT Consultant]
Read More
30-Sep-16 By 2030, the number of elderly people in Asia is forecast to increase by 200 mn, a more than 70 percent increase in contrast to 31 percent in Europe and 55 percent in North America. Marsh & McLennan estimates the cumulative cost of elderly healthcare in Asia over the next 15 years could reach USD20 tn. [image: VOA News]
Read More
30-Sep-16 German medtech firm Biotronik opened an expanded production plant in Singapore. The firm produces implantable pacemakers, defibrillators and stents. "This small nation of 5.5 mn people is the fourth-largest exporter of high-tech goods in the world... We will be manufacturing components for Biotronik's latest and most innovative products for distribution around the world," said Erik Trip, Managing Director. [image: Biotronik]
Read More
30-Sep-16 Bangkok Dusit Medical Services (BDMS), Thailand’s largest hospital operator, plans to spend THB12.8 bn (USD370 mn) to build a luxury healthcare centre to serve rising demand from tourists seeking premium medical services. The clinic will focus on anti-aging, neuroscience and brain health. [image: Customs Today]
Read More
30-Sep-16 The Kim Young-ran Act, which came into force on 28-Sep-16, bans receiving gifts worth more than a certain amount, and complying with unfair requests. The law is also expected to change 'rebate culture,' which harms fair competition in Korea's pharmaceutical industry. For a long time, the culture was pervasive. [image: Business Korea]
Read MoreGGM is a research and advisory firm helping clients grow profitably in international markets.
We believe the only way to understand a market properly is on the ground. Intelligence from our in-country consultants gives you a competitive advantage in China, Asia, Latin America, the Middle East, Africa and other opportunity areas.
Our clients benefit from accurate data, reliable insights and strategic advice, giving them the confidence to make better business decisions and succeed in their global growth markets.
Successful track record in your sector since 1992
In-country research consultants in over 40 markets
Value for money - quality results at affordable rates
Work led by senior directors with >20 years experience
Proven frameworks for data analysis and strategy
Pragmatic advice based on accurate data and reliable insights
Find out more about our international market intelligence and strategy services
Get in touch to discuss your growth markets research and advisory needs:
Email: info@ggmkts.com